Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
Charles B. Nemeroff
American Journal of Psychiatry (2020) Vol. 177, Iss. 8, pp. 671-685
Closed Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
Arash Sadri
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 12651-12677
Closed Access | Times Cited: 61
Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry
Masaru Tanaka, Simone Battaglia, Lydia Giménez‐Llort, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 790-790
Open Access | Times Cited: 19
Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry
Masaru Tanaka, Simone Battaglia, Lydia Giménez‐Llort, et al.
(2024)
Open Access | Times Cited: 17
Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium
Nooshin Javaheripour, Meng Li, Tara Chand, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Large-Scale Transcriptomics Studies Provide Insight Into Sex Differences in Depression
Marianne L. Seney, Jill R. Glausier, Etienne Sibille
Biological Psychiatry (2021) Vol. 91, Iss. 1, pp. 14-24
Open Access | Times Cited: 65
Depression in Osteoarthritis: Current Understanding
Shen-Tao Wang, Guo‐Xin Ni
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 375-389
Open Access | Times Cited: 51
Phosphatidylserine, inflammation, and central nervous system diseases
Xiaohua Ma, Xiaojing Li, Wenjuan Wang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 44
The role of the hypothalamic-pituitary-adrenal axis in depression across the female reproductive lifecycle: current knowledge and future directions
Liisa Hantsoo, Kathleen M. Jagodnik, Andrew M. Novick, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26
Augmented microglial endoplasmic reticulum-mitochondria contacts mediate depression-like behavior in mice induced by chronic social defeat stress
Jiarui Zhang, Shi-Yu Shen, Meng-Ying Zhai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art
E. Van Assche, Josep Antoni Ramos‐Quiroga, Carmine M. Pariante, et al.
European Neuropsychopharmacology (2022) Vol. 60, pp. 100-116
Open Access | Times Cited: 35
Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
Margarida Alberto, Ana Cláudia Paiva‐Santos, Francisco Veiga, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2742-2742
Open Access | Times Cited: 30
The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder
Jeffrey R. Strawn, Jeffrey A. Mills, Vikram Suresh, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 266-273
Open Access | Times Cited: 17
Diagnostic accuracy and clinical utility of the PHQ-2 and GAD-2: a comparison with long-format measures for depression and anxiety
Jón Ingi Hlynsson, Per Carlbring
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 7
Anti-neuroinflammatory effect of hydroxytyrosol: a potential strategy for anti-depressant development
Shuaiguang Li, Huarong Shao, Ting Sun, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine
Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
FBXL20 promotes synaptic impairment in depression disorder via degrading vesicle-associated proteins
Wenjing Wang, Ye Li, Liyan Wang, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 132-144
Closed Access | Times Cited: 5
Individual-Specific Animated Profiles of Mental Health
Sigal Zilcha‐Mano
Perspectives on Psychological Science (2024)
Open Access | Times Cited: 5
Antidepressant effects of the traditional Chinese herbal formula Xiao-Yao-San and its bioactive ingredients
Yating Wang, Xiaole Wang, Zhen‐Zhen Wang, et al.
Phytomedicine (2022) Vol. 109, pp. 154558-154558
Closed Access | Times Cited: 24
Intertwined associations between oxytocin, immune system and major depressive disorder
Junliang Jiang, Miaoxian Yang, Mi Tian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114852-114852
Open Access | Times Cited: 15
The separation distress hypothesis of depression – an update and systematic review
Douglas F. Watt
Neuropsychoanalysis (2023) Vol. 25, Iss. 2, pp. 103-159
Open Access | Times Cited: 14
Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review
Octavian Vasiliu
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 411-411
Open Access | Times Cited: 13
A comparative study between two manufacturing processes for venlafaxine-loaded niosome (Nioven) production: optimization, characterization, pharmacokinetic investigations, depression management, and gene assessment
Reza Enayatifard, Jafar Âkbari, Majid Saeedi, et al.
Journal of Dispersion Science and Technology (2025), pp. 1-17
Closed Access
Compromised B-cell homeostasis: Unraveling the link between major depression, infection and autoimmune disorders
Yuye Yin, Yuan Liu, Longfei Du, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 565-578
Closed Access
Healthcare resource utilization and costs of using Cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder
Prakash S. Masand, Anita H. Clayton, Mousam Parikh, et al.
Journal of Medical Economics (2025) Vol. 28, Iss. 1, pp. 235-244
Open Access
Eupalinolide B alleviates corticosterone-induced PC12 cell injury and improves depression-like behaviors in CUMS rats by regulating the GSK-3β/β-catenin pathway
Tiantian Wang, Meng‐yuan Zhou, Xue-na Gong, et al.
Biochemical Pharmacology (2025) Vol. 235, pp. 116831-116831
Closed Access
Page 1 - Next Page

Scroll to top